Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 20/20 | 0.67 |
| ▸ | INSR | P06213 | 15/20 | 0.67 |
| ▸ | NPM1 | P06748 | 8/20 | 0.61 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17703361 | 0.89 | ALK (0.76) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1546050 | 0.89 | ALK (0.76) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL17703347 | 0.82 | ALK (0.67) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1545746 | 0.81 | ALK (0.77) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1545581 | 0.81 | ALK (0.83) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1546389 | 0.81 | ALK (0.84) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL17703363 | 0.79 | ALK (0.84) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1546320 | 0.79 | ALK (0.84) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL1953609 | 0.79 | ALK (0.86) | ALKINSRNPM1KCNH2CYP3A4 | |
| SCHEMBL4056789 | 0.79 | ALK (0.85) | ALKINSRNPM1KCNH2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3012249-A1 | COMPOUNDS AND COMPOSITION AS PROTEIN KINASE INHIBITORS | Novartis AG (CH) | 2016-04-27 | — | — | EP | disclosed |